Polynovo PNV.AX · AUD

Its shares trade on ASX under the ticker PNV.AX. It has been listed since 26 November 1998. In the fiscal year to 30 June 2026, it reported revenue of A$143.7m and net income of A$7.3m. At that date it held total assets of A$132.5m and shareholders' equity of A$90.7m.

Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria. The firm designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Its development program covers Breast Sling, Hernia and Orthopedic application. NovoSorb is a family of proprietary medical grade polymers that can be utilized to manufacture novel medical devices designed to support tissue repair and which then bio reabsorb in a defined fashion in-situ to harmless by-products. The company manufactures NovoSorb polymer devices with the ability to elute drugs, antimicrobials as well as be expressed in a variety of physical formats, including films, foam, coatings/sprays, fibers, plastic structures and biological carrier. Its NovoSorb Biodegradable Temporising Matrix (BTM) is used in a fully debrided clean surgical wound to physiologically close the wound.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. David WilliamsNon-Executive Independent Chairman of the BoardA$139,429
• Mr. Swami RaoteChief Executive OfficerA$1.5m
• Mr. Jan GielenChief Financial OfficerA$308,070
• Mr. Ed GraubartPresident - North America
• Mr. David MorrisPresident - Asia Pacific
• Ms. Ingrid AndersonChief People Officer
• Dr. David McQuillanChief Technical and Scientific Officer, since 2012A$424,157
• Mr. Philip ScorgieChief Information OfficerA$253,614
• Dr. Aurore MulkensVice President - Quality Affairs
• Mr. Lior HarelGeneral Counsel, Company Secretary
• Mr. Joseph AmaralChief Medical Officer
• Mr. Ahmed HassanDirector of Operations

Overall

45

Environment

15

Social

75

Governance

46

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.